• Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Moderate Buy" from Analysts

    Источник: Buzz FX / 02 фев 2025 02:56:10   America/New_York


    Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 2, 2025 Share Link copied to clipboard. Shares of Ionis Pharmaceuticals, Inc.
    Read more...
Опубликовать